PCN-101
PCN-101-21
Phase 2 small_molecule completed
Quick answer
PCN-101 for Treatment Resistant Depression is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Treatment Resistant Depression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed